• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗精神病药物在养老院痴呆患者身体攻击行为治疗中的疗效。

The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes.

作者信息

Nawzad Sina, Cahn Wiepke, Abdullah-Koolmees Heshu

机构信息

Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.

Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Ther Adv Psychopharmacol. 2022 May 16;12:20451253221097452. doi: 10.1177/20451253221097452. eCollection 2022.

DOI:10.1177/20451253221097452
PMID:35600754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9118396/
Abstract

Patients with dementia often suffer from behavioral changes. A common behavioral change is acute physical aggressive behavior which is the most distressing change. This can lead to harm, which is especially problematic in nursing homes. Despite the serious safety concerns, antipsychotics are often prescribed to combat this problem. This article is aimed to review the evidence of the efficacy of utilizing antipsychotics in acutely treating physical aggressive behavior in patients with dementia in nursing homes. Therefore, a systematic literature search was performed. The results demonstrated that a meta-analysis confirmed statistically significant reduction in physical aggression when risperidone was compared to placebo. However, a randomized controlled trial showed no change in physical aggressive behavior between quetiapine and placebo. More research is needed to fully investigate the benefits of physical aggressive behavior and safety concerns of all the antipsychotics in patients with dementia in nursing homes.

摘要

患有痴呆症的患者经常会出现行为变化。一种常见的行为变化是急性身体攻击性行为,这是最令人痛苦的变化。这可能会导致伤害,在养老院中这一问题尤为突出。尽管存在严重的安全隐患,但抗精神病药物常被用于解决这一问题。本文旨在综述在养老院中使用抗精神病药物急性治疗痴呆症患者身体攻击性行为的疗效证据。因此,进行了系统的文献检索。结果表明,一项荟萃分析证实,与安慰剂相比,利培酮在统计学上能显著减少身体攻击行为。然而,一项随机对照试验显示,喹硫平和安慰剂之间在身体攻击行为方面没有变化。需要更多的研究来全面调查养老院中痴呆症患者身体攻击行为的益处以及所有抗精神病药物的安全隐患。

相似文献

1
The efficacy of antipsychotics in the treatment of physical aggressive behavior in patients with dementia in nursing homes.抗精神病药物在养老院痴呆患者身体攻击行为治疗中的疗效。
Ther Adv Psychopharmacol. 2022 May 16;12:20451253221097452. doi: 10.1177/20451253221097452. eCollection 2022.
2
A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.一项关于利培酮治疗痴呆症攻击行为、激越和精神病的随机安慰剂对照试验。
J Clin Psychiatry. 2003 Feb;64(2):134-43. doi: 10.4088/jcp.v64n0205.
3
Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.与痴呆相关的激越、攻击行为和精神病的管理:一项汇总分析,包括三项在接受利培酮治疗的疗养院居民中进行的随机、安慰剂对照双盲试验。
Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. doi: 10.1016/j.clineuro.2005.03.013.
4
Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.对三个患有痴呆症和行为障碍的养老院患者大样本进行科恩-曼斯菲尔德激越量表的因素分析。
Am J Geriatr Psychiatry. 2005 Nov;13(11):991-8. doi: 10.1176/appi.ajgp.13.11.991.
5
Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.评估非典型抗精神病药治疗痴呆行为和心理症状的报告比较有效性和安全性:网络荟萃分析。
JAMA Netw Open. 2019 Mar 1;2(3):e190828. doi: 10.1001/jamanetworkopen.2019.0828.
6
Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.以人为主的照护训练和活动对养老院老年痴呆患者生活质量、激越和抗精神病药物使用的影响:一项整群随机对照试验。
PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb.
7
Measurement of aggressive behaviors in dementia: comparison of the physical aggression subscales of the Cohen-Mansfield Agitation Inventory and the Ryden Aggression Scale.痴呆症攻击行为的测量:科恩-曼斯菲尔德激越量表与赖登攻击量表身体攻击分量表的比较
Res Gerontol Nurs. 2013 Jul;6(3):171-7. doi: 10.3928/19404921-20130321-01. Epub 2013 Mar 28.
8
Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.痴呆患者的行为和心理症状作为利培酮药物治疗的靶点。
J Clin Psychiatry. 2004 Oct;65(10):1329-34. doi: 10.4088/jcp.v65n1006.
9
The efficacy and safety of atypical antipsychotics for the treatment of dementia: a meta-analysis of randomized placebo-controlled trials.非典型抗精神病药物治疗痴呆症的疗效和安全性:随机安慰剂对照试验的荟萃分析
J Alzheimers Dis. 2014;42(3):915-37. doi: 10.3233/JAD-140579.
10
Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study.喹硫平治疗痴呆患者激越症状:一项随机、双盲、安慰剂对照研究。
Curr Alzheimer Res. 2007 Feb;4(1):81-93. doi: 10.2174/156720507779939805.

引用本文的文献

1
Gender differences in the French Caribbean nursing homes.法属加勒比地区养老院中的性别差异。
Sci Rep. 2025 Feb 20;15(1):6170. doi: 10.1038/s41598-025-90740-7.

本文引用的文献

1
Development of a Methodological Quality Criteria List for Observational Studies: The Observational Study Quality Evaluation.观察性研究方法学质量标准清单的制定:观察性研究质量评估
Front Res Metr Anal. 2021 Jul 14;6:675071. doi: 10.3389/frma.2021.675071. eCollection 2021.
2
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
3
An update on the advancements in the treatment of agitation in Alzheimer's disease.阿尔茨海默病激越治疗进展的最新情况。
Expert Opin Pharmacother. 2017 Apr;18(6):611-620. doi: 10.1080/14656566.2017.1307340. Epub 2017 Mar 28.
4
A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice.养老院中抗精神病药物用于痴呆症治疗的共识指南。弥合科学证据与临床实践之间的差距。
Int Psychogeriatr. 2015 Nov;27(11):1849-59. doi: 10.1017/S1041610215000745. Epub 2015 Jun 10.
5
Dosage and duration of antipsychotic treatment in demented outpatients with agitation or psychosis.老年痴呆门诊患者激越或精神病的抗精神病药物治疗剂量与疗程
J Formos Med Assoc. 2015 Feb;114(2):147-53. doi: 10.1016/j.jfma.2012.09.002. Epub 2012 Oct 27.
6
Atypical antipsychotic use in patients with dementia: managing safety concerns.非典型抗精神病药物在痴呆患者中的应用:管理安全性问题。
Am J Psychiatry. 2012 Sep;169(9):900-6. doi: 10.1176/appi.ajp.2012.12030342.
7
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality.非典型抗精神病药物治疗痴呆的行为和心理症状,特别关注长期结局和死亡率。
Expert Opin Drug Saf. 2011 Jan;10(1):35-43. doi: 10.1517/14740338.2010.506711. Epub 2010 Aug 5.
8
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.CONSORT 2010 声明:平行组随机试验报告的更新指南。
PLoS Med. 2010 Mar 24;7(3):e1000251. doi: 10.1371/journal.pmed.1000251.
9
Quetiapine to treat agitation in dementia: a randomized, double-blind, placebo-controlled study.喹硫平治疗痴呆患者激越症状:一项随机、双盲、安慰剂对照研究。
Curr Alzheimer Res. 2007 Feb;4(1):81-93. doi: 10.2174/156720507779939805.
10
Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.与痴呆相关的激越、攻击行为和精神病的管理:一项汇总分析,包括三项在接受利培酮治疗的疗养院居民中进行的随机、安慰剂对照双盲试验。
Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. doi: 10.1016/j.clineuro.2005.03.013.